: Michael A. Proschan, K. K. Gordon Lan, Janet Turk Wittes
: Statistical Monitoring of Clinical Trials A Unified Approach
: Springer-Verlag
: 9780387449708
: 1
: CHF 129.40
:
: Allgemeines
: English
: 268
: Wasserzeichen/DRM
: PC/MAC/eReader/Tablet
: PDF

The approach taken in this book is, to studies monitored over time, what the Central Limit Theorem is to studies with only one analysis. Just as the Central Limit Theorem shows that test statistics involving very different types of clinical trial outcomes are asymptotically normal, this book shows that the joint distribution of the test statistics at different analysis times is asymptotically multivariate normal with the correlation structure of Brownian motion ('the B-value') - irrespective of the test statistic. Thus, this book offers statisticians an accessible, incremental approach to understanding Brownian motion as related to clinical trials.

Preface7
Contents9
1 Introduction14
2 A General Framework21
2.1 Hypothesis Testing: The Null Distribution of Test Statistics Over Time22
2.2 An Estimation Perspective30
2.3 Connection Between Estimators, Sums, Z-Scores, and Brownian Motion33
2.4 Maximum Likelihood Estimation36
2.5 Other Settings Leading to E-Processes and Brownian Motion40
2.6 The Normal Linear and Mixed Models42
2.7 When Is Brownian Motion Not Appropriate?48
2.8 Summary50
2.9 Appendix51
3 Power: Conditional, Unconditional, and Predictive55
3.1 Unconditional Power55
3.2 Conditional Power for Futility57
3.3 Varied Uses of Conditional Power65
3.4 Properties of Conditional Power69
3.5 A Bayesian Alternative: Predictive Power72
3.6 Summary75
3.7 Appendix76
4 Historical Monitoring Boundaries79
4.1 How Bad Can the Naive Approach Be?79
4.2 The Pocock Procedure81
4.3 The Haybittle Procedure and Variants81
4.4 The O’Brien-Fleming Procedure83
4.5 A Comparison of the Pocock and O’Brien-Fleming Boundaries84
4.6 Effect of Monitoring on Power87
4.7 Appendix: Computation of Boundaries Using Numerical Integration89
5 Spending Functions 92
5.1 Upper Boundaries92
5.2 Upper and Lower Boundaries101
5.3 Summary103
5.4 Appendix103
6 Practical Survival Monitoring 109
6.1 Introduction109
6.2 Survival Trials with Staggered Entry109
6.3 Stochastic Process Formulation and Linear Trends111
6.4 A Real Example112
6.5 Nonlinear Trends of the Statistics: Analogy with Monitoring a t-Test113
6.6 Considerations for Early Termination114
6.7 The Information Fraction with Survival Data115
7 Inference Following a Group-Sequential Trial 122
7.1 Likelihood, Sufficiency, and (Lack of) Completeness122
7.2 One-Tailed p-Values125
7.3 Properties of p-Values134
7.4 Confidence Intervals135
7.5 Estimation140
7.6 Summary144
7.7 Appendix: Proof that B( t ) t Overestimates 0 in the One-Tailed Setting144
8 Options When Brownian Motion Does Not Hold146
8.1 Small Sample Sizes146
8.2 Permutation Tests152
8.3 The Bonferroni Method158
8.4 Summary159
8.5 Appendix160
9 Monitoring for Safety163
9.1 Example: Inference from a Sample Size of One163
9.2 Example: Inference from Multiple Endpoints164
9.3 General Considerations165
9.4 What Safety Data Look Like168
9.5 Looking for a Single Adverse Event171
9.6 Looking for Multiple Adverse Events180
9.7 Summary181
10 Bayesian Monitoring 183
10.1 Introduction183
10.2 The Bayesian Paradigm Applied to B-Values184
10.3 The Need for a Skeptical Prior185
10.4 A Comparison of Bayesian and Frequentist Boundaries188
10.5 Example190
10.6 Summary192
11 Adaptive Sample Size Methods 193
11.1 Introduction193
11.2 Methods Using Nuisance Parameter Estimates: The Continuous Outcome Case194
11.3 Methods Using Nuisance Parameter Estimates: The Binary Outcome Case207
11.4 Adaptive Methods Based on the Treatment Effect211
11.5 Summary218
12 Topics Not Covered 220
12.1 Introduction220
12.2 Continuous Sequential Boundaries221
12.3 Other Types of Group-Sequential Boundaries222
12.4 Reverse Stochastic Curtailing223
12.5 Monitoring Studies with More Than Two Arms224
12.6 Monitoring for Equivalence and Noninferiority225
12.7 Repeated Confidence Intervals225
13 Appendix I: The Logrank and Related Tests227
13.1 Hazard Functions228
13.2 Linear Rank Statistics231
13.3 Payment Functions and Score Functions237
13.4 Censored Survival Data239
13.5 The U-Statistic Approach to the Wilcoxon Statistic240
13.6 The Logrank and Weighted Mantel-Haenszel Statistics241
13.7 Monitoring Survival Trials243
14 Appendix II: Group-Sequential Software 244
14.1 Introduction244
14.2 Before the Trial Begins: Power and Sample Size244
14.3 During the Trial: Computation of Boundaries246
14.4 After the Trial: p-Value, Parameter Estimate, and Confidence Interval247
14.5 Other Features of the Program249
References252
Index260